Diapride

Quick links to important sections

Diapride

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diapride

Quick Facts

Property Description
Active Ingredient Glimepiride
Form Oral tablet
Pharmacological Class Sulfonylurea (Insulin Secretagogue)
Common Use Management of Type 2 diabetes mellitus
Origin / Status Synthetic / Prescription-Only Medicine (POM)

What Type of Medicine is Diapride and What is its Purpose?

Diapride is a specific Prescription-Only Medicine (POM) containing the active ingredient glimepiride, which is primarily used to manage Type 2 diabetes mellitus in adults. Glimepiride belongs to the sulfonylurea pharmacological class, which is a group of drugs designed to lower blood glucose levels.

The core purpose of Diapride is to help patients achieve and maintain effective blood sugar control, a necessity for long-term health. The effectiveness of glimepiride for improving glycemic control is clinically established, confirming the medicine is recognized for its ability to help improve the overall sugar balance in the blood.


Glimepiride: The Composition and Unique Forms of Diapride

The medication's effect comes solely from its active constituent, glimepiride, a synthetic compound that is chemically manufactured. Diapride is often provided as a single-agent tablet (glimepiride only) but is also common in fixed-dose combinations with other drugs like metformin (e.g., Diapride M), which addresses a common clinical need for multi-target therapy.

The standard form is an oral tablet for easy administration. Glimepiride is often classified as a third-generation sulfonylurea, a distinction related to its high potency and long duration of action, which often supports a convenient once-daily regimen.


How Does Diapride Work as a Secretagogue?

Diapride’s fundamental mode of action is as an insulin secretagogue. This means it works chiefly by stimulating the beta cells of the pancreas to increase the release of the body’s own insulin.

This specific action of boosting the residual insulin response sets it apart from other types of diabetes medications that may target glucose absorption in the gut or production in the liver. As the active ingredient meets standards for quality and efficacy in this specific mechanism, it works as intended for its approved use.

Regulatory References

  1. Glimepiride (DailyMed/NIH)
  2. Glimepirida Parke-Davis (EMA referral)

What side effects are possible with Diapride?

Possible Side Effects and Safety Information

Diapride (glimepiride) has an officially documented safety profile characterized primarily by the potential for hypoglycemia (low blood sugar), which is the most frequent adverse reaction listed in regulatory documents. Adverse reactions are classified by the affected System Organ Class (SOC) and incidence rates.


Summary of Documented Adverse Reactions

Classification Example Adverse Reactions Frequency Affected System Organ Class
Most Common Hypoglycemia, Transient visual disturbances, Headache, Dizziness Common Metabolism, Eye, Nervous System
Less Common Thrombocytopenia, Leukopenia, Mild allergic reactions Rare Blood and Lymphatic System
Rare/Serious Hepatic failure, Anaphylactic shock, Severe blood dyscrasias Very Rare Hepatobiliary, Immune System, Blood

Safety Considerations and Restrictions

The risk of hypoglycemia is notably increased in the elderly and in patients with renal or hepatic impairment, as officially stated in the labeling. Transient visual disturbances may be observed, particularly upon the initiation of treatment, due to fluctuations in blood glucose levels.

Glimepiride is contraindicated in certain severe conditions, including Type 1 diabetes mellitus, diabetic ketoacidosis, and severe renal or hepatic function disorders. It is also officially restricted for use during pregnancy and lactation.

Overdose and Emergency Response

Overdose and When to Seek Help

Symptoms that indicate a medical emergency or an overdose situation may involve serious conditions like ketoacidosis and severe hypoglycemia, which may require immediate medical attention or hospitalization.

Documented Urgent Presentations

Condition Symptoms to Recognize (Must Seek Help Immediately)
Ketoacidosis Nausea, vomiting, stomach-area (abdominal) pain, unusual tiredness, and trouble breathing.
Severe Hypoglycemia Confusion, weakness, extreme hunger, sweating, tremor, palpitations, slurred speech, or loss of consciousness.
Severe Infection Signs of a serious urinary tract infection, which can progress to urosepsis or pyelonephritis (e.g., burning when urinating, fever, pain in the lower stomach area, blood in urine).

Emergency Action Required

For Symptoms of Ketoacidosis: Patients must stop taking this medicine and seek medical attention immediately. Patients experiencing these symptoms may be advised to check for ketones in their urine, if possible.

For Symptoms of Severe Hypoglycemia: Instantly consume a fast-acting source of sugar, such as glucose tablets, sugary juice, or honey, and inform a doctor right away, as close monitoring or hospital admission may be necessary for severe cases, especially those involving unconsciousness.

Overdose risk is increased by certain circumstances, including surgery, severe dehydration, acute illness, or excessive alcohol use. If you experience any severe symptoms listed above, contacting a healthcare professional right away is required, even if you are unsure of the cause.

Therapeutic Uses of Diapride

What Diapride Treats: Main Uses and Benefits

Diapride is commonly used to help with managing Type 2 diabetes mellitus in adults. It is indicated for use as an adjunct to diet and exercise for managing blood sugar. This medication is applied in situations where persistently high blood sugar (hyperglycemia) is not adequately addressed by lifestyle changes alone, or when combined with other agents.


The main therapeutic use involves addressing symptoms related to systemic imbalance, supporting management of long-term glycemic markers (HbA1c), and is relevant for combination therapy scenarios. This medication may be part of a management plan for the chronic condition, assisting with the goal of stabilizing blood sugar. The primary benefit is that it contributes to improved comfort by supporting a more stable blood sugar balance, which assists with maintaining functional stability.


Quick Fact: Relief for Unstable Glucose
Main Use: Applied in chronic conditions marked by persistently high glucose levels, and is relevant when monotherapy alone is insufficient.
Key Benefit: Contributes to improved long-term well-being by addressing elevated HbA1c values.
Clinical Context: Used in sequential or combination therapy to support the goal of stable blood sugar management.

Eligibility and Restrictions for Use

Eligibility Map: Who can and Cannot Use Diapride

Diapride, which contains glimepiride, is officially approved for use in adults with Type 2 diabetes mellitus. Eligibility for this medicine is strictly defined by regulatory documents based on certain conditions and patient populations.


Absolute Contraindications (Must Not Use)

Classification Population Status
Hypersensitivity Contraindicated in patients with known allergy to glimepiride, other sulfonylureas, or sulfonamide derivatives.
Comorbidity Contraindicated for patients with Type 1 diabetes mellitus or diabetic ketoacidosis.
Organ Function Contraindicated in cases of severe renal impairment and severe hepatic impairment.

Restricted and Non-Established Use

Classification Population Status
Age Safety and effectiveness have not been established in the pediatric population (under 18).
Physiological State Contraindicated during pregnancy and not recommended during lactation.
Special Caution Older adults and patients with mild to moderate renal or hepatic impairment require careful dose consideration due to heightened risk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Diapride (Glimepiride) is primarily defined by two regulatory categories: Pharmacodynamic Alteration and Pharmacokinetic Modification.

Pharmacodynamic Potentiation

Co-administration of Glimepiride with certain medicinal products can lead to a clinically significant potentiation of the blood-glucose-lowering action. This is specifically documented with agents such as Insulin and other oral antidiabetic agents. Regulatory information also documents that the concomitant use of Miconazole (oral) can result in severe hypoglycemia. Conversely, substances like Glucocorticoids or certain Thiazide diuretics may officially weaken the blood-glucose-lowering effect. Alcohol consumption has an officially documented effect that may unpredictably potentiate or weaken the hypoglycaemic action.

Pharmacokinetic and Administration Constraints

Glimepiride's clearance is subject to CYP2C9 enzyme metabolism. Co-administration with CYP2C9 inhibitors (e.g., Fluconazole) may lead to increased plasma concentrations of Glimepiride, while inducers (e.g., Rifampicin) may cause decreased plasma concentrations. Furthermore, agents that interfere with gastrointestinal absorption, such as Colesevelam, reduce Glimepiride exposure; therefore, official regulatory documents require Glimepiride must be administered at least 4 hours prior to Colesevelam. A specific interaction caution exists for individuals with Glucose 6-Phosphate Dehydrogenase (G6PD) deficiency, where treatment with sulfonylureas may lead to hemolytic anaemia.

Mechanism of Action

The final, verified mechanistic text.

Targeted Inhibition of the K ATP Channel in Beta Cells

Glimepiride's action is fundamentally a molecular trigger, achieved by binding to the Sulfonylurea Receptor 1 (SUR1) subunit of the ATP-sensitive potassium channel (K ATP) on the pancreatic beta cell membrane, causing its closure. This inhibition halts the efflux of potassium, which facilitates the depolarization of the cell membrane and initiates the subsequent release of the hormone.


Driving the Insulin Secretion Cascade

The resulting membrane depolarization activates voltage-dependent calcium channels, leading to a massive influx of calcium ions (Ca^2+). This calcium surge acts as the direct second messenger, compelling the insulin storage granules to fuse with the cell membrane and exocytose the hormone into the circulation. This sequence results in an increased rate and volume of insulin secretion.


Accelerating Systemic Glucose Utilization

Beyond its primary role as a secretagogue, glimepiride also exhibits extrapancreatic activity, promoting the movement of glucose from the blood into peripheral tissues like muscle. This mechanism improves the efficiency of glucose uptake, resulting in accelerated glucose clearance from the systemic circulation.

Dosage and Administration Information

How Diapride is Used: Official Dosing and Administration

This section outlines the instructions for using Diapride (glimepiride), detailing administration and standard dosing protocols for the management of the condition.


Official Administration Instructions

Category Official Instruction
Route of Administration Oral (by mouth)
Timing in Relation to Meals Must be taken once daily with the first main meal of the day (e.g., breakfast).
Preparation The tablet should be swallowed whole with liquid.
Missed Dose If a dose is missed, do not take a double dose; simply continue with the next scheduled dose.

Standard Labeled Dosing Regimen

Diapride treatment is initiated at a low dose and adjusted gradually based on response.

  • Initial Dose: The starting dose is typically 1 mg or 2 mg once daily.
  • Dose Adjustment (Titration): Dose increases should not occur more frequently than every 1 to 2 weeks to allow the body to adjust. Increases are made in 1 mg or 2 mg increments.
  • Maximum Recommended Daily Dose: The maximum recommended daily dose typically ranges from 6 mg to 8 mg, taken once daily depending on specific clinical guidelines.

Population-Specific Use

For specific populations, caution is recommended:

  • Older Adults and Renal Impairment: For older adults or patients with mild-to-moderate renal impairment, a conservative starting dose of 1 mg once daily is utilized due to potential sensitivity and accumulation.

These instructions establish a structured protocol for the standardized use of this medicine.

Recent Clinical Evidence

Diapride: Recent Clinical Evidence

Research has examined the use of glimepiride for Type 2 diabetes mellitus in adults, primarily through Randomized Controlled Trials (RCTs) and systematic reviews. Studies were designed to observe changes in key physiological markers, mainly focusing on glycated hemoglobin ( HbA1c) and short-term blood sugar levels (FPG, PPG).

Glimepiride was evaluated both alone and in combination therapy with other established agents like metformin, with findings generally describing patterns where shifts in these glycemic biomarkers were observed during the study periods. Comparative trials have explored how glimepiride was evaluated against other anti-diabetic medications, examining differences in outcomes such as patterns in C-peptide and insulin responses. Findings from these trials were observed to be mixed or dependent on the comparator and study length.

Extended clinical trials and observational studies monitored outcomes reflecting functional stability, such as the durability of blood sugar control over years. Long-term evidence was observed in studies examining major clinical events (e.g., cardiovascular death, stroke). However, this long-term evidence is derived from settings with varying symptom burdens, and these findings data show patterns related to association, not controlled causation.

Research has also examined specific populations. Studies explored the pharmacokinetics of glimepiride in patients with varying levels of reduced kidney function, and research describes how its breakdown products may accumulate. However, evidence is limited for long-term clinical outcomes in severe renal impairment. Data for children remains insufficient.

Overall, comparative evidence is lacking for long-term clinical endpoints against newer drug classes, and the follow-up durations were limited in many earlier trials. Research provides context but not individual predictions.

Key Studies & References

  1. Comparative efficacy of glimepiride and metformin in monotherapy of type 2 diabetes mellitus: meta-analysis of randomized controlled trials
  2. Comparative Evaluation of Safety and Efficacy of Glimepiride and Sitagliptin in Combination with Metformin in Patients with Type 2 Diabetes Mellitus: Indian Multicentric Randomized Trial (START Study)
  3. Summary of Product Characteristics (SmPC) for Amaryl (Glimepiride) - Indications and Renal Impairment

Frequently Asked Questions (FAQ)

Common questions about Diapride (FAQ)

Q: How quickly should Diapride start lowering my blood sugar?

A: Official product information, based on pharmacokinetic studies, indicates that Diapride (glimepiride) is absorbed quickly after taking it. Significant drug absorption typically occurs within one hour, with the maximum amount of the drug reaching the bloodstream within 2 to 3 hours. This timing is intended to coordinate the drug’s peak activity with the expected post-meal rise in blood glucose.

Q: How does Diapride compare to Metformin for type 2 diabetes management?

A: Regulatory information indicates that Diapride works as an insulin secretagogue, meaning it stimulates the pancreas to release more of its own insulin. Metformin, on the other hand, works by improving your body's response to insulin differently. Because they target different processes, regulatory documents note that Diapride may be used in combination with metformin to help manage blood sugar, supporting a multi-target therapy approach.

Q: What are the most common side effects people report when taking Diapride?

A: According to official regulatory documents summarizing clinical trials, some of the most common adverse reactions reported by patients include hypoglycemia (low blood sugar), headache, nausea, and dizziness. It is important to be aware of the potential for low blood sugar.

Q: Is weight gain a typical side effect of Diapride?

A: While regulatory documents for single-agent Diapride (glimepiride) do not list weight gain as a common adverse reaction, it has been observed in clinical data for some combination products that contain glimepiride. Medications that increase insulin release are generally recognized as potentially being associated with weight changes.

Q: What are the long-term effects of taking Diapride?

A: Diapride is an oral medication indicated for the long-term management of Type 2 diabetes. Official prescribing information notes that clinical studies have not conclusively established that glimepiride reduces the risk of macrovascular complications (problems affecting the large blood vessels).

Q: Can Diapride affect my Vitamin B12 levels?

A: Official labeling for single-agent Diapride does not indicate that glimepiride affects Vitamin B12 levels. However, if Diapride is taken as part of a fixed-dose combination medicine that includes metformin, that combination product does carry warnings that metformin may potentially cause a decrease in Vitamin B12 levels.

Q: What is the risk of lactic acidosis associated with Diapride combination medicines?

A: Official product labeling for Diapride (glimepiride) does not list lactic acidosis as a risk for the single-agent drug. However, many combination medicines containing Diapride also include metformin, and those products carry an official Boxed Warning about the risk of metformin-associated lactic acidosis, a serious metabolic complication.

Q: Why is Diapride taken immediately before a meal?

A: The recommended timing for Diapride is with the first main meal of the day. This timing is linked to the drug's mechanism as a secretagogue, which is designed to stimulate insulin release to coincide with the post-meal rise in blood glucose.

Q: Is it normal to feel dizzy or nauseous when first starting Diapride?

A: Official clinical trial reports list dizziness and nausea as common adverse reactions. These effects are often observed by patients when they begin treatment.

Q: Is Diapride considered a 'last resort' diabetes drug?

A: Official regulatory documents indicate that Diapride is suitable for use as an initial drug therapy for adults with Type 2 diabetes, when used alongside diet and exercise. It is an established treatment option and is not restricted for use as a final option.

Q: Do lifestyle changes like diet and exercise still matter when taking Diapride?

A: Yes, regulatory documentation clearly states that Diapride is indicated for use as an adjunct to diet and exercise. This means the medication is officially intended to be used in addition to, not as a replacement for, continuing your recommended lifestyle changes.

Q: Does Diapride interact with blood pressure medications?

A: Regulatory information documents that the blood-glucose-lowering effect of Diapride can be affected by certain medications. For example, some ACE inhibitors and thiazide diuretics, which may be used to treat blood pressure, are listed in regulatory documents as potentially affecting Diapride's blood-glucose-lowering action.

Q: Is Diapride known to cause headaches or flu-like symptoms?

A: Official reports from clinical trials list headache as a common adverse reaction. However, generalized flu-like symptoms are not explicitly listed among the most frequently reported side effects in the regulatory documentation.

Q: Can taking Diapride affect my ability to drive or operate machinery?

A: Regulatory patient information states that the ability to concentrate and react may be impaired by the risk of hypoglycemia (low blood sugar). This potential impairment should be considered when driving or operating machinery.

Q: What is the typical duration of treatment with Diapride?

A: Diapride is indicated for the management of Type 2 diabetes mellitus. Because Type 2 diabetes is typically a chronic, long-term condition, the use of this medication is generally intended to be part of an ongoing treatment plan.

Q: Does Diapride help reduce the long-term complications of diabetes?

A: Official regulatory warnings advise that, based on clinical studies, there has been no conclusive evidence established that Diapride or any other oral anti-diabetic drug reduces the risk of macrovascular complications (problems affecting the large blood vessels).

Q: What are the ingredients in Diapride tablets besides the active drug?

A: According to the official description, Diapride tablets contain the active ingredient glimepiride as well as several inactive ingredients, or excipients. These can include lactose, povidone, microcrystalline cellulose, and magnesium stearate, and sometimes coloring agents, depending on the tablet strength.

Q: Is Diapride a commonly prescribed medicine for newly diagnosed type 2 diabetes?

A: Official regulatory indications and clinical trial summaries show that Diapride is effective and indicated for use as an initial drug therapy for adults who are newly diagnosed with Type 2 diabetes, when used in conjunction with diet and exercise.

Q: Can other types of drugs, like antibiotics, interact with Diapride?

A: Yes, official regulatory documents list several types of drugs that can interact. For example, certain oral antifungals like miconazole, and other agents, may potentiate Diapride's blood-glucose-lowering effect, which could potentially lead to severe hypoglycemia.

Q: If I am ill or under stress, should I temporarily stop taking Diapride?

A: Due to the risk of hypoglycemia, the official guidance for 'sick day rules' recommends that patients who are unable to eat or are fasting should consult a healthcare professional regarding temporary adjustments to their medication schedule.

Q: Why might Diapride need to be stopped before a planned surgery?

A: Regulatory documents mention that, due to the increased risk of hypoglycemia during periods of fasting required for surgery, Diapride may need to be temporarily discontinued as part of a pre-operative plan.

Q: Does the color or shape of the Diapride tablet indicate its strength?

A: Yes, official documentation on the drug's dosage forms and strengths confirms that the physical characteristics, such as the color, size, and shape of the tablet, are specifically linked to the milligram strength of the medicine.

Q: Do all combination forms of Diapride contain Metformin?

A: While Diapride (glimepiride) is most commonly found in fixed-dose combinations with metformin, it is also officially available in combination with other anti-diabetic agents, such as pioglitazone.

How should Diapride be stored and disposed of?

Diapride (glimepiride) tablets must be stored according to specific regulatory requirements to maintain their stability and effectiveness.

Storage Requirements

Condition Requirement
Temperature Do not store above 25 C (Room Temperature).
Protection Keep away from heat, moisture, and direct light. Do not freeze.
Child Safety Store securely out of the reach and sight of children.

Disposal

Do not keep medicine that is expired or no longer needed. Official instructions require that you ask a pharmacist or healthcare professional for guidance on the correct way to dispose of unused medicine. Do not flush Diapride down the toilet unless specifically instructed to do so by the manufacturer or a take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Diapride found in:

A-Z Index: